Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: celeryroot.com who wrote (241)	1/29/1998 11:13:00 AM
From: Apache Indian	Respond to of 1494

Somebody play the devils advocate here please, coz. I bot more of this stock in the last 1/2 hour. I now have 7500 shares at an avg. price of 1.45 !! As far as I am concerened, the biggest threat was the failure of memantine in Phase II, thats gone; what remains is the cash problem, but I dont think this company is going to buckle down, it has gone this far with memantine, it shall find some strategic partners soon, its almost impossible to see this company folding up at this stage. 1 $ should be the bottom at this point. Thats only 6 1/2 mil. $ mkt. cap. What have I got to lose ? A lot to gain certainly ( I think !) Dont want to be left with the hindsight thing again. Somebody scare me with that patents thing please !! Could any pharma company produce memantine based drug for diabetes without partenering with NTI ? Thats the only worry I have right now. But thats a !B I G! one. -indian